TherapeuticsMD
TXMD
#10765
Rank
โ‚ฌ17.67 M
Marketcap
1,53ย โ‚ฌ
Share price
-1.72%
Change (1 day)
30.71%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2023 (TTM): 4,21ย โ‚ฌ

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is 0,07143ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 11,21ย โ‚ฌ an increase over its 2021 EPS that were of -19,38ย โ‚ฌ.

EPS history for TherapeuticsMD from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)4,21ย โ‚ฌ-62.42%
202211,21ย โ‚ฌ-157.83%
2021-19,38ย โ‚ฌ-35.22%
2020-29,91ย โ‚ฌ-5.63%
2019-31,70ย โ‚ฌ20.34%
2018-26,34ย โ‚ฌ55.26%
2017-16,97ย โ‚ฌ-19.15%
2016-20,98ย โ‚ฌ-6%
2015-22,32ย โ‚ฌ42.86%
2014-15,63ย โ‚ฌ52.17%
2013-10,27ย โ‚ฌ-41.03%
2012-17,41ย โ‚ฌ-93.62%
2011-273,03ย โ‚ฌ-65.57%
2010-792,95ย โ‚ฌ88.66%
2009-420,32ย โ‚ฌ-32.78%
2008-625,29ย โ‚ฌ16.59%
2007-536,33ย โ‚ฌ26.96%
2006-422,44ย โ‚ฌ-11743.27%
20053,63ย โ‚ฌ-101.88%
2004-192,89ย โ‚ฌ-554.77%
200342,41ย โ‚ฌ216.55%
200213,40ย โ‚ฌ-85.01%
200189,39ย โ‚ฌ369.94%
200019,02ย โ‚ฌ434.56%
19993,56ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,68ย โ‚ฌ 850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
3,19ย โ‚ฌ 4,363.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-3,46ย โ‚ฌ-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
1,67ย โ‚ฌ 2,244.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-22,57ย โ‚ฌ-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA